Humana (HUM) Stock Forecast & Price Target

Compare

2,605 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HUM Analyst Ratings

Moderate Buy

8 Buy

14 Hold

1 Sell

Based on 23 analysts giving stock ratings to

Humana

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$293.45

▲(6.71% Upside)

Based on 23 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $293.45 with a high forecast of $347.00 and a low forecast of $224.00. The average price target represents a 6.71% change from the last price of $275.01.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"223":"$223","348":"$348","254.25":"$254.3","285.5":"$285.5","316.75":"$316.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":347,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$347.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":293.45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$293.45</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":224,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$224.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[223,254.25,285.5,316.75,348],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,246.77,254.48000000000002,262.19,269.9,277.61,285.32,293.03,300.74,308.45,316.15999999999997,323.87,331.58,339.28999999999996,{"y":347,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,246.77,250.36076923076925,253.95153846153846,257.5423076923077,261.13307692307694,264.7238461538461,268.31461538461537,271.9053846153846,275.49615384615385,279.0869230769231,282.67769230769227,286.2684615384615,289.85923076923075,{"y":293.45,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,246.77,245.01846153846154,243.2669230769231,241.51538461538462,239.76384615384617,238.0123076923077,236.26076923076923,234.50923076923078,232.7576923076923,231.00615384615384,229.2546153846154,227.50307692307692,225.75153846153847,{"y":224,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":275.58,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":257.1,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":289.07,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 43, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.07,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.18,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.61,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":262.84,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.21,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":229.73,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":308.98,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.77,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$347.00

Average Price Target$293.45

Lowest Price Target$224.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Soren Coverra

TR | OpenAI - 4o

$314

Buy

14.18%

Upside

Reiterated

10/18/25

AI Generated ArticleAI Generated Article

Lance Wilkes

Bernstein

$341

Buy

24.00%

Upside

Reiterated

10/16/25

Bernstein Remains a Buy on Humana (HUM)

Ben Hendrix

RBC Capital

$322

Buy

17.09%

Upside

Reiterated

10/15/25

Humana (HUM) Gets a Buy from RBC Capital

Andrew Mok CFA

Barclays

$245

Hold

-10.91%

Downside

Reiterated

10/15/25

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (NASDAQ: APLS), Impedimed Limited (Other OTC: IPDQF) and Humana (NYSE: HUM)

David S Macdonald

Truist Financial

$280→$300

Hold

9.09%

Upside

Reiterated

10/14/25

Humana price target raised to $300 from $280 at TruistHumana price target raised to $300 from $280 at Truist

Scott Fidel

Goldman Sachs

$235

Sell

-14.55%

Downside

Initiated

10/14/25

Goldman Sachs Initiates a Sell Rating on Humana (HUM)

Sarah James

Cantor Fitzgerald

$290

Hold

5.45%

Upside

Reiterated

10/10/25

Cantor Fitzgerald Sticks to Its Hold Rating for Humana (HUM)Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating and $290.00 price target on Humana (NYSE: HUM).

Whit Mayo

Leerink Partners

$273

Hold

-0.73%

Downside

Reiterated

10/10/25

Humana (HUM) Receives a Hold from Leerink Partners

Kevin Fischbeck

Bank of America Securities

$280→$300

Hold

9.09%

Upside

Reiterated

10/10/25

Analysts Offer Insights on Healthcare Companies: CVS Health (NYSE: CVS), Stoke Therapeutics (NASDAQ: STOK) and Humana (NYSE: HUM)Raising HUM from $280 (11.7x 2027E EPS) to $300 (12.5x 2027E EPS) ... We reiterate Neutral on HUM based on balanced risk-reward.

Ann Hynes

Mizuho Securities

$300→$345

Buy

25.45%

Upside

Reiterated

10/08/25

Humana price target raised to $345 from $300 at MizuhoHumana price target raised to $345 from $300 at Mizuho

Justin Lake

Wolfe Research

$283→$313

Buy

13.81%

Upside

Reiterated

10/06/25

Humana (HUM) Gets a Buy from Wolfe ResearchWolfe Research analyst Justin Lake raised the price target on Humana (NYSE: HUM) to $313.00 (from $283.00) while maintaining a Outperform rating.

Stephen Baxter

Wells Fargo

$344→$347

Buy

26.18%

Upside

Reiterated

10/06/25

Humana price target raised to $347 from $344 at Wells FargoHumana price target raised to $347 from $344 at Wells Fargo

Michael Wiederhorn

Oppenheimer

$310

Buy

12.72%

Upside

Reiterated

10/03/25

Humana (HUM) Gets a Buy from Oppenheimer

Erin Wright

Morgan Stanley

$277

Hold

0.72%

Upside

Reiterated

10/02/25

Humana's Strategic Initiatives to Enhance Medicare Advantage Performance and Financial Margins

Jason Cassorla

Guggenheim

$326

Buy

18.54%

Upside

Reiterated

10/02/25

Guggenheim Remains a Buy on Humana (HUM)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Soren Coverra

TR | OpenAI - 4o

$314

Buy

14.18%

Upside

Reiterated

10/18/25

AI Generated ArticleAI Generated Article

Lance Wilkes

Bernstein

$341

Buy

24.00%

Upside

Reiterated

10/16/25

Bernstein Remains a Buy on Humana (HUM)

Ben Hendrix

RBC Capital

$322

Buy

17.09%

Upside

Reiterated

10/15/25

Humana (HUM) Gets a Buy from RBC Capital

Andrew Mok CFA

Barclays

$245

Hold

-10.91%

Downside

Reiterated

10/15/25

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (NASDAQ: APLS), Impedimed Limited (Other OTC: IPDQF) and Humana (NYSE: HUM)

David S Macdonald

Truist Financial

$280→$300

Hold

9.09%

Upside

Reiterated

10/14/25

Humana price target raised to $300 from $280 at TruistHumana price target raised to $300 from $280 at Truist

Scott Fidel

Goldman Sachs

$235

Sell

-14.55%

Downside

Initiated

10/14/25

Goldman Sachs Initiates a Sell Rating on Humana (HUM)

Sarah James

Cantor Fitzgerald

$290

Hold

5.45%

Upside

Reiterated

10/10/25

Cantor Fitzgerald Sticks to Its Hold Rating for Humana (HUM)Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating and $290.00 price target on Humana (NYSE: HUM).

Whit Mayo

Leerink Partners

$273

Hold

-0.73%

Downside

Reiterated

10/10/25

Humana (HUM) Receives a Hold from Leerink Partners

Kevin Fischbeck

Bank of America Securities

$280→$300

Hold

9.09%

Upside

Reiterated

10/10/25

Ann Hynes

Mizuho Securities

$300→$345

Buy

25.45%

Upside

Reiterated

10/08/25

Humana price target raised to $345 from $300 at MizuhoHumana price target raised to $345 from $300 at Mizuho

Justin Lake

Wolfe Research

$283→$313

Buy

13.81%

Upside

Reiterated

10/06/25

Humana (HUM) Gets a Buy from Wolfe ResearchWolfe Research analyst Justin Lake raised the price target on Humana (NYSE: HUM) to $313.00 (from $283.00) while maintaining a Outperform rating.

Stephen Baxter

Wells Fargo

$344→$347

Buy

26.18%

Upside

Reiterated

10/06/25

Humana price target raised to $347 from $344 at Wells FargoHumana price target raised to $347 from $344 at Wells Fargo

Michael Wiederhorn

Oppenheimer

$310

Buy

12.72%

Upside

Reiterated

10/03/25

Humana (HUM) Gets a Buy from Oppenheimer

Erin Wright

Morgan Stanley

$277

Hold

0.72%

Upside

Reiterated

10/02/25

Humana's Strategic Initiatives to Enhance Medicare Advantage Performance and Financial Margins

Jason Cassorla

Guggenheim

$326

Buy

18.54%

Upside

Reiterated

10/02/25

Guggenheim Remains a Buy on Humana (HUM)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

1 Month

xxx

Success Rate

24/39 ratings generated profit

Average Return

+1.33%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 61.54% of your transactions generating a profit, with an average return of +1.33% per trade.

3 Months

xxx

Success Rate

26/39 ratings generated profit

Average Return

+2.22%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +2.22% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

24/39 ratings generated profit

Average Return

+4.49%

reiterated a buy rating 17 days ago

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +4.49% per trade.

2 Years

xxx

Success Rate

29/39 ratings generated profit

Average Return

+11.06%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 74.36% of your transactions generating a profit, with an average return of +11.06% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HUM has received 21 Buy Ratings, 21 Hold Ratings, and 1 Sell Ratings. HUM average Analyst price target in the past 3 months is 293.45.

Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is $2.93 with a range of $2.13 to $3.35. The previous quarter’s EPS was $6.27. HUM beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $32.00B with a range of $31.40B to $32.21B. The previous quarter’s sales results were $32.39B. HUM beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year HUM has Preformed in-line its overall industry.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?

Based on analyst ratings, Humana Inc’s 12-month average price target is 293.45.

What is HUM’s upside potential, based on the analysts’ average price target?

Humana Inc has 6.71% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HUM a Buy, Sell or Hold?

Humana Inc has a consensus rating of Moderate Buy which is based on 8 buy ratings, 14 hold ratings and 1 sell ratings.

What is Humana Inc’s price target?

The average price target for Humana Inc is 293.45. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $347.00 ,the lowest forecast is $224.00. The average price target represents 6.71% Increase from the current price of $275.01.

What do analysts say about Humana Inc?

Humana Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Streets Analysts.

How can I buy shares of HUM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Humana (HUM) Stock Forecast & Price Target

HUM Analyst Ratings

HUM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Humana

HUM Analyst Recommendation Trends

HUM Financial Forecast

HUM Earnings Forecast

HUM Sales Forecast

HUM Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts